Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 8/20 | 0.41 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.40 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 2/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CETP | P11597 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5542790 | 0.79 | ELANE (0.56) | ELANEFAAHMAOBMAOAALDH1A1 | |
| SCHEMBL3954800 | 0.79 | PSMB8 (0.59) | ELANEPSMB8PSMB5MAOBMAOA | |
| SCHEMBL9305490 | 0.76 | ACHE (0.43) | PSMB8PSMB5MAOBMAOAALDH1A1 | |
| SCHEMBL1121502 | 0.76 | PSMB8 (0.40) | ELANEPSMB8PSMB5MAOBMAOA | |
| SCHEMBL288107 | 0.76 | NUDT1 (0.56) | ELANEFAAHMAOBMAOAALDH1A1 | |
| SCHEMBL1463176 | 0.76 | GABRP (0.41) | ELANEPSMB8PSMB5MAOBMAOA | |
| SCHEMBL5542784 | 0.76 | ELANE (0.41) | ELANEFAAHMAOBMAOAALDH1A1 | |
| SCHEMBL6489417 | 0.76 | ELANE (0.41) | ELANEFAAHMAOBMAOAALDH1A1 | |
| SCHEMBL21780802 | 0.76 | FAAH (0.41) | ELANEFAAHMAOBMAOAALDH1A1 | |
| SCHEMBL1121801 | 0.76 | NQO2 (0.46) | ELANEMAOBMAOAALDH1A1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4063368-B1 | NITROGEN-CONTAINING COMPOUND AND ELECTRONIC ELEMENT COMPRISING SAME, AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MAT CO LTD (CN) | 2024-06-26 | — | — | EP | disclosed |
| US-20240025906-A1 | KINASE MODULATORS AND METHODS OF USE THEREOF | SUNDANCE BIOSCIENCES, INC. | 2024-01-25 | — | — | US | disclosed |
| US-20240025906-A1 | KINASE MODULATORS AND METHODS OF USE THEREOF | SUNDANCE BIOSCIENCES, INC. | 2024-01-25 | — | — | US | disclosed |
| US-20230008185-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE INCLUDING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-01-12 | — | — | US | disclosed |
| US-20220274968-A1 | Oxazole And Oxadiazole Derivatives Useful As Agonists Of Free Fatty Acid Receptor 1 | GBIOTECH S.À.R.L. (CH) | 2022-09-01 | — | — | US | disclosed |
| US-8003675-B2 | 3,4-dihalogenoisothiazole derivative, and agricultural or horticultural plant disease-controlling agent | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2011-08-23 | — | — | US | disclosed |
| US-8003675-B2 | 3,4-dihalogenoisothiazole derivative, and agricultural or horticultural plant disease-controlling agent | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2011-08-23 | — | — | US | disclosed |
| WO-2010070822-A1 | SAFENERS FOR HERBICIDES, HERBICIDAL COMPOSITIONS WITH REDUCED CHEMICAL DAMAGE AND SAFENING METHOD USING SAME | クミアイ化学工業株式会社 (JP) | 2010-06-24 | — | — | WO | disclosed |
| US-20090240057-A1 | 3,4-Dihalogenoisothiazole Derivative, and Agricultural or Horticultural Plant Disease-Controlling Agent | KUMIAI CHEMICAL INDUSTRY CO., LTD. AND IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2009-09-24 | — | — | US | disclosed |
| US-20090240057-A1 | 3,4-Dihalogenoisothiazole Derivative, and Agricultural or Horticultural Plant Disease-Controlling Agent | KUMIAI CHEMICAL INDUSTRY CO., LTD. AND IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2009-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090240057-A1 | 3,4-Dihalogenoisothiazole Derivative, and Agricultural or Horticultural Plant Disease-Controlling Agent | CBR3, HDHD5, OSR1 | ELANE 4095/4885PSMB8 3615/4885PSMB5 890/4885 |
| US-20230008185-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE INCLUDING SAME | DNTT, EML4, NME1 | ELANE 701/4885PSMB8 3851/4885PSMB5 3439/4885 |
| US-20240025906-A1 | KINASE MODULATORS AND METHODS OF USE THEREOF | TYK2, JAK1, JAK3 | ELANE 4593/4885PSMB8 3755/4885PSMB5 3130/4885 |
| US-20220274968-A1 | Oxazole And Oxadiazole Derivatives Useful As Agonists Of Free Fatty Acid Receptor 1 | FFAR2, FFAR1, FFAR3 | ELANE 4078/4885PSMB8 3068/4885PSMB5 3282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.